Do depressive symptoms correlate with oxidative stress in a sample of healthy college students?

European Journal of Psychiatry

Volumn 24, Issue 2, 2010, Pages 63-69

  Matsushita, Masateru ^a,b,c   Kumano Go, Takayuki ^a,b,c   Suganuma, Nakamori ^a,b,c   Adachi, Hiroyoshi ^a,b,c   Yamanura, Schubei ^a,c   Morishima, Hiroko ^a,c   Shigedo, Yoshihisa ^a,c   Mikami, Akira ^a,b,c   Takeda, Masatoshi ^a,c   Sugita, Yoshiro ^a,b,c  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Depression; Depressive symptoms; Oxidative stress

Indexed keywords

REACTIVE OXYGEN METABOLITE;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; BIOLOGICAL ANTIOXIDANT POTENTIAL TEST; BLOOD LEVEL; BLOOD SAMPLING; COLLEGE STUDENT; CONTROLLED STUDY; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; FEMALE; HUMAN; HUMAN EXPERIMENT; LABORATORY TEST; MALE; NORMAL HUMAN; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS; SCORING SYSTEM; SEX DIFFERENCE; SLEEP; SYMPTOM;

EID: 77954636618     PISSN: 02136163     EISSN: None     Source Type: Journal    
DOI: 10.4321/S0213-61632010000200001     Document Type: Article

References (28)

1. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 1998; 55(7): 580-592.
2. Rudisch B, Nemeroff CB. Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry 2003; 54(3): 227-240.
3. Lett HS, Blumenthal JA, Babyak MA, Sherwood A, Strauman T, Robins C, et al. Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med 2004; 66(3): 305-315.
4. Larson SL, Owens PL, Ford D, Eaton W. Depressive disorder, dysthymia, and risk of stroke: thirteen-year follow-up from the Baltimore epidemiologic catchment area study. Stroke 2001; 32(9): 1979-1983.
5. Penninx BW, Guralnik JM, Pahor M, Ferrucci L, Cerhan JR, Wallace RB, et al. Chronically depressed mood and cancer risk in older persons. J Natl Cancer Inst 1998; 90(24): 1888-1893.
6. Raison CL, Miller AH. Depression and cancer: new developments regarding diagnosis and treatment. Biol Psychiatry 2003; 54(3): 283-294.
7. Spiegel D, Giese-Davis J. Depression and cancer: mechanisms and disease progression. Biol Psychiatry 2003; 54(3): 269-282.
8. Musselman DL, Betan E, Larsen H, Phillips LS. Relationship of depression to diabetes type 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry 2003; 54(3): 317-329.
9. Eaton WW. Epidemiologic evidence on the comorbidity of depression and diabetes. J Psychosom Res 2002; 53(4): 903-906.
10. Eaton WW, Armenian H, Gallo J, Pratt L, Ford DE. Depression and risk for onset of type II diabetes. A prospective population-based study. Diabetes Care 1996; 19(10): 1097-1102.
11. Ng F, Berk M, Dean O, Bush AI. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol 2008; 11(6): 851-876.
12. Atabek ME, Vatansev H, Erkul I. Oxidative stress in childhood obesity. J Pediatr Endocrinol Metab 2004; 17(8): 1063-1068.
13. Digiesi V, Oliviero C, Giannò V, Rossetti M, Fiorillo C, Oradei A, et al. Reactive metabolites of oxygen, lipid peroxidation, total antioxidant capacity and vitamin E in essential arterial hypertension. Clin Ter 1997; 148(11): 515-519.
14. Katsabeki-Katsafli A, Kerenidi T, Kostikas K, Dalaveris E, Kiropoulos TS, Gogou E, et al. Serum vascular endothelial growth factor is related to systemic oxidative stress in patients with lung cancer. Lung Cancer 2008; 60(2): 271-276.
15. Cesarone MR, Belcaro G, Carratelli M, Cornelli U, De Sanctis MT, Incandela L, et al. A simple test to monitor oxidative stress. Int Angiol 1999; 18(2): 127-130.
16. Yanik M, Erel O, Kati M. The relationship between potency of oxidative stress and severity of depression. Acta Neuropsychiatrica 2004; 16(4): 200-203.
17. Irie M, Miyata M, Kasai H. Depression and possible cancer risk due to oxidative DNA damage. J Psychiatr Res 2005; 39(6): 553-560.
18. Irie M, Asami S, Ikeda M, Kasai H. Depressive state relates to female oxidative DNA damage via neutrophil activation. Biochem Biophys Res Commun 2003; 331(4): 1014-1018.
19. Kojima M, Furukawa TA, Takahashi H, Kawai M, Nagaya T, Tokudome S. Cross-cultural validation of the Beck Depression Inventory-II in Japan. Psychiatry Res 2002; 110(3): 291-299.
20. Forlenza MJ, Miller GE. Increased serum levels of 8-hydroxy-2'-deoxyguanosine in clinical depression. Psychosom Med 2006; 68(1): 1-7.
21. Tsuboi H, Shimoi K, Kinae N, Oguni I, Hori R, Kobayashi F. Depressive symptoms are independently correlated with lipid peroxidation in a female population: comparison with vitamins and carotenoids. J Psychosom Res 2004; 56(1): 53-58.
22. Bilici M, Efe H, Köroǧlu MA, Uydu HA, Bekaroǧlu M, Deǧer O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord 2001; 64(1): 43-51.
23. Ansseau M. Diagnostice and therapeutic usefulness of biological markers of depression. University of Liège, Thèse d' Agrégation; 1992.
24. Kasckow JW, Baker D, Geracioti TD Jr. Corticotropin-releasing hormone in depression and post-traumatic stress disorder. Peptides 2001; 22(5): 845-851.
25. Maes M, Lambrechts J, Bosmans E, Jacobs J, Suy E, Vandervorst C, et al. Evidence for a systemic immune activation during depression, results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining. Psychol Med 1992; 22(1): 45-53.
26. Deǧer O, Bekaroǧlu M, Orem A, Orem S, Uluutku N, Soylu C. Polymorphonuclear (PMN) elastase levels in depressive disorders. Biol Psychiatry 1996; 39(5): 357-363.
27. Seidel A, Arolt V, Hunstiger M, Rink L, Behnisch A, Kirchner H. Increased CD56+ natural killer cells and related cytokines in major depression. Clin Immunol Immunopathol 1996; 78(1): 83-85.
28. Sluzewska A, Rybakowski J, Bosmans E, Sobieska M, Berghmans R, Maes M, et al. Indicators of immune activation in major depression. Psychiatry Res 1996; 64(3): 161-167.